Publication Cover
Ozone: Science & Engineering
The Journal of the International Ozone Association
Volume 37, 2015 - Issue 4
476
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

The Efficacy of Ozone/BAC Treatment on Non-Steroidal Anti-Inflammatory Drug Removal from Drinking Water and Surface Water

, , , &
Pages 343-356 | Received 02 Sep 2014, Accepted 15 Dec 2014, Published online: 11 Jun 2015

REFERENCES

  • Adams, C., Y. Wang, K. Loftin, and M. Meyer 2002. “Removal of Antibiotics from Surface and Distilled Water in Conventional Water Treatment Processes.” Journal of Environmental Engineering 128(3): 253–260. DOI:10.1061/(ASCE)0733-9372(2002)128:3(253)
  • Aizpuru, A., L. Malhautier, J.C. Roux, and J.L. Fanlo 2003. “Biofiltration of a Mixture of Volatile Organic Compounds on Granular Activated Carbon.” Biotechnology and Bioengineering 83(4): 479–488.
  • Alvares, A.B., C. Diaper, and S.A. Parsons 2001. “Partial oxidation by ozone to remove recalcitrance from wastewaters-a review.” Environmental Technology 22(4): 409–427.
  • Barham M., and A.W. Anderson. 1997. “Non-Steroidal Anti-Inflammatory Drugs(NSAIDs)” Advances in Experimental Medicine & Biology 21(4−6): 541–556. DOI:10.1007/978-1-4899-1825-3_35
  • Brozinski, J.M., M. Lahti, A. Meierjohann, A. Oikari, and L. Kronberg 2013. “The anti-inflammatory drugs diclofenac, naproxen and ibuprofen are found in the bile of wild fish caught downstream of a wastewater treatment plant.” Environmental Science and Technology., 47(1): 342–348.
  • Chiang, Y.P., Y.Y. Liang, C.N. Chang, and A.C. Chao 2006. “Differentiating ozone direct and indirect reactions on decomposition of humic substances.” Chemosphere 65(11): 2395–2400.
  • Cleuvers, M. 2004. “Mixture Toxicity of the Anti-inflammatory Drugs Diclofenac, Ibuprofen, Naproxen, and Acetylsalicylic Acid.” Ecotoxicology and Environmental Safety 59(3): 309–315.
  • Corcoran, J., M.J. Winter, and C.R. Tyler 2010. “Pharmaceuticals in the Aquatic Environment: A Critical Review of the Evidence for Health Effects in Fish.” Critical Reviews in Toxicology 40(4): 287–304.
  • Cuong, D.M., K.W. Kim, T.Q. Toan, and T.D. Phu 2011. “Review: Source, Fate, Toxicological Effect and Removal Technology of Pharmaceuticals in the Environment.” Geosystem Engineering 14(1): 35–42.
  • Deborde, M., S. Rabouan, J.P. Duguet, and B. Legube 2005. “Kinetics of Aqueous Ozone-Induced Oxidation of Some Endocrine Disruptors.” Environmental Science and Technology 39(16): 6086–6092.
  • DellaGreca, M., M. Brigante, M. Isidori, A. Nardelli, L. Previtera, M. Rubino, and F. Temussi 2003. “Phototransformation and Ecotoxicity of the Drug Naproxen-Na.” Environmental Chemistry Letters 1(4): 237–241.
  • Eaton, A.D., L.S. Clesceri, A.E. Greenberg, and M.A.H. Franson 1995. Standard Methods for the Examination of Water and Wastewater. Washington, DC: American Public Health Association.
  • Escher, B.I., N. Bramaz, and C. Ort 2009. “JEM spotlight: Monitoring the Treatment Efficiency of a Full Scale Ozonation on a Sewage Treatment Plant with a Mode-Of-Action Based Test Battery.” Journal of Environmental Monitoring 11(10): 1836–1846.
  • Escher, B.I., and K. Fenner 2011. “Recent Advances in Environmental Risk Assessment of Transformation Products.” Environmental Science and Technology 45(9): 3835–3847.
  • Farré, M.l., S. Pérez, L. Kantiani, and D. Barceló 2008. “Fate and Toxicity of Emerging Pollutants, Their Metabolites Aand Transformation Products in the Aquatic Environment.” TrAC - Trends in Analytical Chemistry 27(11): 991–1007.
  • Feng, L., E.D. van Hullebusch, M.A. Rodrigo, G. Esposito, and M.A. Oturan 2013. “Removal of Residual Anti-Inflammatory Aand Analgesic Pharmaceuticals From Aqueous Systems by Electrochemical Advanced Oxidation Processes. A Review.” Chemical Engineering Journal 228: 944–964.
  • Feng, L., N. Oturan, E. van Hullebusch, G. Esposito, and M.A. Oturan 2014. “Degradation of Anti-Inflammatory Drug Ketoprofen by Electro-Oxidation: Comparison of Electro-Fenton and Anodic Oxidation Processes.” Environmental Science and Pollution Research 21(14): 8406–8416.
  • Graham, N. 1999. “Removal of Humic Substances by Oxidation/Biofiltration Processes—A Review.” Water Science and Technology 40(9): 141–148.
  • Gur-Reznik, S., I. Katz, and C.G. Dosoretz 2008. “Removal of Dissolved Organic Matter by Granular-Activated Carbon Adsorption as a Pretreatment to Reverse Osmosis of Membrane Bioreactor Effluents.” Water Research 42(6–7): 1595–1605.
  • Gustavson, K.E., A. Svenson, and J.M. Harkin 1998. “Comparison of Toxicities and Mechanism of Action of N-Alkanols in the Submitochondrial Particle and the Vibrio fischeri Bioluminescence (Microtox) Bioassay.” Environmental Toxicology and Chemistry 17(10): 1917–1921.
  • Hanna, K., S. Chiron, and M.A. Oturan 2005. “Coupling Enhanced Water Solubilization With Cyclodextrin to Indirect Electrochemical Treatment for Pentachlorophenol Contaminated Soil Remediation.” Water Research 39(12): 2763–2773.
  • Hashim, N.H., and S.J. Khan 2011. “Enantioselective Analysis of Ibuprofen, Ketoprofen and Naproxen in Wastewater and Environmental Water Samples.” Journal of Chromatography A, 1218(29): 4746–4754.
  • Heberer, T. 2002. “Tracking Persistent Pharmaceutical Residues From Municipal Sewage to Drinking Water.” Journal of Hydrology, 266(3–4): 175–189.
  • Hoigné, J. and H. Bader 1976. “The Role of Hydroxyl Radical Reactions in Ozonation Processes in Aqueous Solutions.” Water Research 10(5): 377–386.
  • Hsu, Y.H., Y.B. Liou, J.A. Lee, C.Y. Chen, and A.B. Wu 2006. “Assay of Naproxen by High-Performance Liquid Chromatography and Identification of its Photoproducts by LC-ESI MS.” Biomedical Chromatography 20(8): 787–793.
  • Huber, M.M., S. Canonica, G.Y. Park, and U. von Gunten 2003. “Oxidation of Pharmaceuticals During Ozonation and Advanced Oxidation Processes.” Environmental Science & Technology 37(5): 1016–1024.
  • Huber, M.M., A. Göbel, A Joss, N. Hermann, D. Löffler, C.S. McArdell, A. Ried, H. Siegrist, T.A. Ternes, and U. von Gunten 2005. “Oxidation of Pharmaceuticals during Ozonation of Municipal Wastewater Effluents: A Pilot Study.” Environmental Science & Technology 39(11): 4290–4299.
  • Ikehata, K., N. Jodeiri Naghashkar, and M. Gamal El-Din 2006. “Degradation of Aqueous Pharmaceuticals by Ozonation and Advanced Oxidation Processes: A Review.” Ozone: Science & Engineering 28(6): 353–414.
  • Inotai, A., B. Hanko, and A. Meszaros 2010. “Trends in the Non-Steroidal Anti-Inflammatory Drug Market in Six Central-Eastern European Countries Based on Retail Information.” Pharmacoepidemiology and Drug Safety 19(2): 183–190.
  • Isidori, M., M. Lavorgna, A. Nardelli, A. Parrella, L. Previtera, and M. Rubino 2005. “Ecotoxicity of Naproxen and its Phototransformation Products.” Science of The Total Environment 348(1–3): 93–101.
  • Islas-Flores, H., L.M. Gomez-Olivan, M. Galar-Martinez, A. Colin-Cruz, N. Neri-Cruz, and S. Garcia-Medina 2013. “Diclofenac-Induced Oxidative Stress in Brain, Liver, Gill and Blood of Common Carp (Cyprinus carpio).” Ecotoxicology and Environmental Safety 92: 32–38.
  • Javier Benitez, F., J.L. Acero, F.J. Real, and G. Roldan 2009. “Ozonation of Pharmaceutical Compounds: Rate Constants and Elimination in Various Water Matrices.” Chemosphere 77(1): 53–59.
  • Joss, A., S. Zabczynski, A. Gobel, B. Hoffmann, D. Loffler, C.S. McArdell, T.A. Ternes, A. Thomsen, and H. Siegrist 2006. “Biological Degradation of Pharmaceuticals in Municipal Wastewater Treatment: Proposing a Classification Scheme.” Water Research 40(8): 1686–1696.
  • Jung, H., K.-D. Sohn, B. Neppolian, and H. Choi, 2008. “Effect of Soil Organic Matter (SOM) and Soil Texture on the Ffatality of Indigenous Microorganisms in Integrated Ozonation and Biodegradation.” Journal of Hazardous Materials 150(3): 809–817.
  • Kar, S., and K. Roy 2012. “Risk Assessment for Ecotoxicity of Pharmaceuticals—An Emerging Issue.” Expert Opinion on Drug Safety 11(2): 235–274.
  • Khetan, S.K., And T.J. Collins 2007. “Human Pharmaceuticals In The Aquatic environment: a Challenge to Green Chemistry.” Chemical Reviews 107(6): 2319–2364.
  • Kosjek, T., S. Perko, E. Heath, B. Kralj, and D. Zigon 2011. “Application of Complementary Mass Spectrometric Techniques to the Identification of Ketoprofen Phototransformation Products.” Journal of Mass Spectrometry 46(4): 391–401.
  • Krasner S, W., M.J. Sclimenti, and B.M. Coffey 1993. “Testing Biologically Active Filters for Removing Aldehydes Formed During Ozonation.” Journal American Water Works Association 85(5): 62–71.
  • Lee, J., H. Park, and J. Yoon 2003. “Ozonation Characteristics of Bisphenol A in Water.” Environmental Technology 24(2): 241–248.
  • Lindqvist, N., T. Tuhkanen, and L. Kronberg 2005. “Occurrence of Acidic Pharmaceuticals in Raw and Treated Sewages and in Receiving Waters.” Water Research 39(11): 2219–2228.
  • Loraine, G.A. and M.E. Pettigrove 2006. “Seasonal Variations in Concentrations of Pharmaceuticals and Personal Care Products in Drinking Water and Reclaimed Wastewater in Southern California.” Environmental Science & Technology 40(3): 687–695.
  • Marco-Urrea, E., M. Perez-Trujillo, P. Blanquez, T. Vicent, and G. Caminal 2010. “Biodegradation of the Analgesic Naproxen by Trametes Versicolor and Identification of Intermediates Using HPLC-DAD-MS and NMR.” Bioresource Technology 101(7): 2159–2166.
  • Marotta, R., D. Spasiano, I. Di Somma, and R Andreozzi 2013. “Photodegradation of Naproxen and its Photoproducts in Aqueous Solution at 254 nm: A Kinetic Investigation.” Water Research 47(1): 373–383.
  • Maycock, D.S., and C.D. Watts 2011 “Pharmaceuticals in Drinking Water.”. In Encyclopedia of Environmental Health Personal Care Products and Pharmaceuticals, edited by O.N. Jerome, 472–484. Burlington, UK: Elsevier.
  • McGettigan, P., and D. Henry 2013. “Use of Non-steroidal Anti-inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-income Countries.” PLOS Medicine 10(2): e1001389.
  • Musson, S.E., and T.G. Townsend 2009. “Pharmaceutical Compound Content of Municipal Solid Waste.” Journal of Hazardous Materials 162(2–3): 730–735.
  • Mvula, E., and C. von Sonntag 2003. “Ozonolysis of Phenols in Aqueous Solution.” Organic & Biomolecular Chemistry 1(10): 1749–1756.
  • Pena, M., M. Coca, G. Gonzalez, R. Rioja, and M.T. Garcia 2003. “Chemical Oxidation of Wastewater From Molasses Fermentation with Ozone.” Chemosphere 51(9): 893–900.
  • Peter, A., and U. Von Gunten 2007. “Oxidation Kinetics of Selected Taste and Odor Compounds During Ozonation of Drinking Water.” Environmental Science & Technology 41 (2):626–631.
  • Quintana, J.B., S. Weiss, and T. Reemtsma 2005. “Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor”, Water Res., 39(12): 2654–2664.
  • Real, F.J., F.J. Benitez, J.L. Acero, J.J.P. Sagasti, and F. Casas 2009. “Kinetics of the Chemical Oxidation of the Pharmaceuticals Primidone, Ketoprofen, and Diatrizoate in Ultrapure and Natural Waters.” Industrial & Engineering Chemistry Research 48(7): 3380–3388.
  • Reungoat, J., B.I. Escher, M. Macova, F.X. Argaud, W. Gernjak, and J. Keller 2012. “Ozonation and Biological Activated Carbon Filtration of Wastewater Treatment Plant Effluents.” Water Research 46(3): 863–872.
  • Reungoat, J., B.I. Escher, M. Macova, and J. Keller 2011. “Biofiltration of Wastewater Treatment Plant Effluent: Effective Removal of Pharmaceuticals and Personal Care Products and Reduction of Toxicity.” Water Research 45(9): 2751–2762.
  • Rice, R.G. 1996. “Applications of Ozone for Industrial Wastewater Treatment—A Review.” Ozone: Science & Engineering 18(6): 477–515.
  • Richardson, M.L., and J.M. Bowron 1985. “The Fate of Pharmaceutical Chemicals in the Aquatic Environment.” Journal of Pharmacy and Pharmacology 37(1): 1–12.
  • Rittmann, B.E., D. Stilwell, J.C. Garside, G.L. Amy, C. Spangenberg, A. Kalinsky, and E. Akiyoshi 2002. “Treatment of a Colored Groundwater by Ozone-Biofiltration: Pilot Studies and Modeling Interpretation.” Water Research, 36(13): 3387–3397.
  • Salgado, R., V.J. Pereira, G. Carvalho, R. Soeiro, V. Gaffney, C. Almeida, V. Vale Cardoso, E. Ferreira, M.J. Benoliel, T.A. Ternes, A. Oehmen, M.A. Reis, and J.P. Noronha. 2013. “Photodegradation Kinetics and Transformation Products of Ketoprofen, Diclofenac and Atenolol in Pure Water and Treated Wastewater.” Journal of Hazardous Materials 244–245:516–527.
  • Scheytt, T.J., P. Mersmann, and T. Heberer 2006. “Mobility of Pharmaceuticals Carbamazepine, Diclofenac, Ibuprofen, and Propyphenazone in Miscible-Displacement Experiments.” Journal of Contaminant Hydrology 83(1–2): 53–69.
  • Siddiqui, M.S., G.L. Amy, and B.D. Murphy 1997. “Ozone Enhanced Removal of Natural Organic Matter From Drinking Water Sources.” Water Research 31(12): 3098–3106.
  • Staehelin, J., and J. Hoigné, 1982. “Decomposition of Ozone in Water: Rate of Initiation by Hydroxide Ions and Hydrogen Peroxide.” Environmental Science & Technology 16(10): 676–681.
  • Staehlin, J., and J. Hoigné 1985. “Decomposition of Ozone in Water in the Presence of Organic Solutes Acting as Promoters and Inhibitors of Radical Chain Reactions.” Environmental Science and Technology 19(12): 1206–1213.
  • Stasinakis, A.S., S. Mermigka, V.G. Samaras, E. Farmaki, and N.S. Thomaidis 2012. “Occurrence of Endocrine Disrupters and Selected Pharmaceuticals in Aisonas River (Greece) and Environmental Risk Assessment Using Hazard Indexes.” Environmental Science and Pollution Research 19(5): 1574–1583.
  • Tewari, S., R. Jindal, Y.L. Kho, S. Eo, and K. Choi 2013. “Major Pharmaceutical Residues in Wastewater Treatment Plants and Receiving Waters in Bangkok, Thailand, and Associated Ecological Risks.” Chemosphere 91(5): 697–704.
  • Thanomsub, B., V. Anupunpisit, S. Chanphetch, T. Watcharachaipong, R. Poonkhum, and C. Srisukonth 2002. “Effects of Ozone Treatment on Cell Growth and Ultrastructural Changes in Bacteria.” The Journal of General and Applied Microbiology 48(4): 193–199.
  • Tizaoui, C., L. Bouselmi, L. Mansouri, and A. Ghrabi 2007. “Landfill Leachate Treatment with Ozone and Ozone/Hydrogen Peroxide Systems.” Journal of Hazardous Materials 140(1–2): 316–324.
  • Umar, M., F. Roddick, L. Fan, and H.A. Aziz, 2013. “Application of Ozone for the Removal of Bisphenol A From Water and Wastewater—A Review.” Chemosphere 90(8): 2197–2207. DOI:10.1016/j.chemosphere.2012.09.090
  • Vieno, N.M., H. Härkki, T. Tuhkanen, and L. Kronberg 2007. “Occurrence of Pharmaceuticals in River Water and Their Elimination in a Pilot-Scale Drinking Water Treatment Plant.” Environmental Science & Technology, 41(14): 5077–5084.
  • Westerhoff, P., G. Aiken, G. Amy, and J. Debroux 1999. “Relationships between the structure of natural organic matter and its reactivity towards molecular ozone and hydroxyl radicals.” Water Research 33(10): 2265–2276.
  • Yu, H., E. Nie, J. Xu, S. Yan, W.J. Cooper, and W. Song 2013. “Degradation of Diclofenac by Advanced Oxidation and Reduction Processes: Kinetic Studies, Degradation Pathways and Toxicity Assessments.” Water Research 47(5): 1909–1918.
  • Zearley, T.L. and R.S. Summers 2012. “Removal of Trace Organic Micropollutants by Drinking Water Biological Filters.” Environmental Science & Technology 46(17): 9412–9419.
  • Ziylan, A. and N.H. Ince 2011. “The Occurrence and Fate of Anti-inflammatory and Analgesic Pharmaceuticals in Sewage and Fresh Water: Treatability by Conventional and Non-Conventional Processes.” Journal of Hazardous Materials 187(1–3): 24–36.
  • Zwiener, C., and F.H. Frimmel 2000. “Oxidative Treatment of Pharmaceuticals in Water.” Water Research, 34(6): 1881–1885.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.